BCBS insurers’ $2.7B antitrust settlement gets preliminary approval

A U.S. district judge gave preliminary approval for a $2.7 billion settlement from Blue Cross Blue Shield insurers. The settlement is for an antitrust lawsuit that accuses the companies of conspiring to divide markets and avoid directly competing with each other. 

Advertisement

In a Nov. 30 order, U.S. District Judge R. David Proctor in the Northern District of Alabama gave early blessing to the settlement, which would resolve the claims in the original lawsuit brought by BCBS plan members.

The claims were first brought in 2012 under a class-action lawsuit filed on behalf of health plan members. The lawsuit alleged that anticompetitive behavior among BCBS plans has led to higher prices for members. 

For a deeper dive into what the settlement entails, click here.

More articles on payers:
Radiologists to Cigna: Revise hospital-based imaging policy to avoid harming pediatric patients
UnitedHealth expects $277B+ in revenue in 2021
New Jersey school board sues Horizon, says insurer threatened to stop paying claims for 14,000 workers

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Legal & Regulatory Issues

Advertisement

Comments are closed.